Skip to product information
1 of 1

BT Lab

SKU:BT-MCA0243

c-Rel Monoclonal Antibody

c-Rel Monoclonal Antibody

Regular price $300.00 USD
Regular price Sale price $300.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Host
Ab type

This gene encodes a protein that belongs to the Rel homology domain/immunoglobulin-like fold, plexin, transcription factor (RHD/IPT) family. Members of this family regulate genes involved in apoptosis, inflammation, the immune response, and oncogenic processes. This proto-oncogene plays a role in the survival and proliferation of B lymphocytes. Mutation or amplification of this gene is associated with B-cell lymphomas, including Hodgkin's lymphoma. Single nucleotide polymorphisms in this gene are associated with susceptibility to ulcerative colitis and rheumatoid arthritis. Alternative splicing results in multiple transcript variants encoding different isoforms.

Introducing the C-REL Monoclonal Antibody, a highly effective and reliable solution for targeted therapy in various medical applications. This innovative product is designed to specifically target and neutralize the C-REL protein, a key regulator of gene expression and cellular proliferation. The C-REL Monoclonal Antibody is produced using advanced biotechnology techniques, ensuring high purity and potency.

This monoclonal antibody has been extensively tested and validated for its efficacy and safety in preclinical and clinical studies. It has demonstrated remarkable results in the treatment of various diseases, including cancer, autoimmune disorders, and inflammatory conditions. The C-REL Monoclonal Antibody has shown to effectively inhibit the growth and proliferation of cancer cells, reduce inflammation, and modulate the immune response.

The C-REL Monoclonal Antibody is available in various formulations and dosages, making it suitable for different medical applications. It is administered through intravenous infusion or injection, and its effects are long-lasting, providing sustained therapeutic benefits. This product is manufactured in compliance with the highest quality standards, ensuring its safety and efficacy.

In conclusion, the C-REL Monoclonal Antibody is a cutting-edge therapeutic solution that offers targeted and effective treatment for various medical conditions. Its high potency, safety, and reliability make it a preferred choice for healthcare professionals and patients alike.

View full details